Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9810.
-
Democrats’ midterm win raises scrutiny on AI infrastructure projectsDemocratic control may lead to stricter AI regulations, impacting data center growth and potentially altering Big Tech investment strategies. The post Democrats’ midterm win raises scrutiny on AI infrastructure projects appeared first on Crypto Briefing .
-
Bitcoin Rallies 2%: Could Tightening Supply Spark a Bigger Rally?Bitcoin rises 2% as shrinking tradable supply and record shark-wallet accumulation fuel hopes of a supply squeeze, though ownership concentration poses
-
THORChain's RUNE jumps 10% as North Korean hackers resume laundering Binance lootNorth Korea’s TraderTraitor is routing Binance hack proceeds through THORChain, swapping ether for bitcoin after an earlier wave of conversions from Tron.
-
New Project Backed by Ripple Co-Founder Faces Heavy XRP Community BacklashA project backed by Ripple's co-founder sparks massive XRP community backlash after offloading tokens immediately following its launch.
-
These Analysts Slash Their Forecasts On Booking Holdings Following Q3 ResultsBooking Holdings beat Q3 estimates with EPS of $4.66 and sales of $9.793B; shares rose 1.4%. Analysts cut price targets to $150 and $219.
-
Super Group (SGHC) Q3 2026 Earnings Call TranscriptSuper Group (SGHC) (NYSE:SGHC) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
-
These Analysts Revise Their Forecasts On AMD After Q3 ResultsAMD beat Q3 revenue and earnings estimates, forecast strong Q4 growth, and saw mixed analyst price-target changes.
-
USDC Issuer Circle Quietly Cuts 5% of Staff in Profitable QuarterThe USDC issuer disclosed the cuts in its earnings release, booking $9.1 million in restructuring costs as reserve income fell 8%.
-
Bernstein raises TSMC price target to $600 from $554Bernstein's TSMC target hike underscores the semiconductor industry's supercycle, driven by AI demand and diverse customer growth. The post Bernstein raises TSMC price target to $600 from $554 appeared first on Crypto Briefing .
-
Why South Korea’s Largest US ETF Rallied While Seoul Sold Off — and What the Midterms Mean NextEWY gained 2.27% alongside chip ETFs before the midterm results. What does a Democratic sweep mean for the global AI trade?
-
Estée Lauder CEO Declares 'Best Is Yet To Come' With Ambitious 2030 Growth TargetsEstée Lauder (EL) stock rises after unveiling its 2030 targets and Beauty Reimagined plan following a strong Q1 earnings beat.
-
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For WednesdayAnalysts raised targets for FRSH, EW, ATRC, SUPN and DUOL; cut targets for FLG and AMD. EW was upgraded, while FLG was downgraded.
-
Riot sells 20,264 Bitcoin for $1.5B to fund data center expansionRiot's strategic leases could enhance long-term growth, but managing debt and timely project execution are crucial for sustained success. The post Riot sells 20,264 Bitcoin for $1.5B to fund data center expansion appeared first on Crypto Briefing .
-
The New York Times Company Announces Third-Quarter 2026 Financial ResultsThe New York Times Company scheduled the release of its third-quarter 2026 financial results for November 4, 2026.
-
Circle beats earnings expectations on strong revenue, but cuts 5% of its workforceCircle’s net income for continuing operations of $226 million grew 5% year-over-year to $226 million in the third quarter.
-
Glaukos Insider Executes Significant Share SaleA Glaukos Corporation insider has sold shares valued at approximately $10.6 million, as disclosed in a recent SEC filing.
-
BTIG and Barclays Downgrade Driven BrandsAnalysts at BTIG and Barclays downgraded Driven Brands Holdings Inc. on November 4, 2026, following recent company disclosures regarding financial restatements and lowered earnings guidance.
-
Analyst Adjusts Price Target for BioMarin Pharmaceutical Inc.An analyst has updated the 12-month price target for BioMarin Pharmaceutical Inc. to $90.85.
-
Stella-Jones Announces Normal Course Issuer Bid and Quarterly DividendStella-Jones Inc. received approval for a new normal course issuer bid to repurchase up to 1.5 million common shares and declared a quarterly dividend of $0.34 per share.
-
Stella-Jones Reports Third Quarter 2026 Financial ResultsStella-Jones Inc. announced its financial results for the third quarter ended September 30, 2026, reporting sales of $979 million and adjusted EBITDA of $159 million.